Download Free Sample Report

Oligonucleotide Therapy Market, Global Outlook and Forecast 2023-2032

Oligonucleotide Therapy Market, Global Outlook and Forecast 2023-2032

  • Published on : 14 September 2023
  • Pages :63
  • Report Code:SMR-7812859

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
Although several types of oligonucleotide therapies exist, five of them are compared here, including the ones targeting nucleic acids (such as mRNA) or proteins, as well as others intended for stimulation of the immune system. DDS is generally used with oligonucleotide therapy, as it is difficult for these molecules to penetrate cell membrane when administered on their own.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Therapy. This report contains market size and forecasts of Oligonucleotide Therapy in global, including the following market information:
Global Oligonucleotide Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Oligonucleotide Therapy market was valued at US$ 3784.6 million in 2022 and is projected to reach US$ 4807.5 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biogen is the industry's biggest player, with more than 76 percent of 2018 revenue, followed by Sarepta Therapeutics and Jazz Pharmaceuticals, with 13.35 percent and 6.63 percent, respectively. North America and Europe are the most important regions, accounting for more than 80 percent of the combined income.
We surveyed the Oligonucleotide Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oligonucleotide Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Oligonucleotide Therapy Market Segment Percentages, by Type, 2022 (%)
Antisense Oligonucleotide
Aptamer
Others
Global Oligonucleotide Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Oligonucleotide Therapy Market Segment Percentages, by Application, 2022 (%)
Infectious Diseases
Oncology
Neurodegenerative Disorders
Cardiovascular Diseases
Kidney Diseases
Others
Global Oligonucleotide Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Oligonucleotide Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oligonucleotide Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oligonucleotide Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam Pharmaceuticals Inc.
Biogen
Dynavax Technologies Corp.
Merck and Co.
Miragen Therapeuutics Inc.
Sarepta Therapeutics Inc.
GlaxoSmithKline
Pfizer
Gilead Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oligonucleotide Therapy, market overview.
Chapter 2: Global Oligonucleotide Therapy market size in revenue.
Chapter 3: Detailed analysis of Oligonucleotide Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oligonucleotide Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.